Mednow Investor Presentation Deck

Accretive Acquisitions Create Significant Synergies in the Mednow Ecosystem General Synergies Infrastructure Synergies mednow Description Key Metrics (last fiscal year) - revenue, profits, patients Cross-Selling - more robust offering to win clients and patients National Expansion Technology - integrate into streamlined technology offering Advanced Capabilities -at-home care / specialty pharmacy services People - adds key primary care and specialist physician roster, patient base and industry relationships I TSX-V: MNOW I OTC-QB: MDNWF Medvisit At-home doctor services $3M revenue, -30% gross margin -15.5K active patients √ √ √ √ InfusiCare Pharmacy that specializes in biologics for rheumatology and gastroenterology $9.3M revenue, -12% gross margin -2.7K active patients √ √ √ Liver Specialty Group Pharmacy that specializes in hepatology and the treatment of liver disease $21.3M revenue, ~10% gross margin -2K active patients √ √ √ ✓ √ 19

View entire presentation